Vanessa Lucey, Ph.D., MBA, director of CRI Clinical Accelerator and Venture Fund, speaks on the "Investing into Oncology: Who, What and Where?" panel at Cancer Progress on May 6, 2020, at Convene in New York City.
Since 1989, Cancer Progress invites a discussion of scientific progress within the context of development, regulatory, clinical, commercial and investment perspectives in two days of interactive dialogue. This conference offers pivotal topics, frank discussions, vigorous debate, lively audience participation, and generous networking throughout the meeting during breaks, luncheons, reception, and dinner.
The 31st Annual Meeting on May 5-6, 2020, provides a quality learning experience with experienced speakers, breadth and depth of coverage, and value of professional contacts.
Cancer Progress is organized by Cello Health BioConsulting.
Photos courtesy of Cello Health BioConsulting